American International Group’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
PA
KCM
KCM
EAM
American International Group's ALDX Position: Q2 2024 in Review
American International Group sold out of Aldeyra Therapeutics (ALDX) in Q2 2024, closing a stake of 22,952 shares — an estimated $75.1K sold.
American International Group first reported a position in ALDX in Q2 2018 and held it in 16 quarters. The position peaked at $233K in Q3 2021. 103 funds tracked by Wall St. Rank hold ALDX as of Q2 2024.
- American International Group reported no remaining Aldeyra Therapeutics position as of Q2 2024 after selling out during the quarter.
- American International Group sold 22,952 Aldeyra Therapeutics shares in Q2 2024, an estimated $75.1K.
- American International Group first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 16 quarters.
- American International Group's Aldeyra Therapeutics position peaked at $233K in Q3 2021.
- 103 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.